Business Context and Reporting Period
Company: iSpecimen Inc. (ISPC)
Filing Type: Form 8-K (Current Report)
Report Date: September 19, 2024 (Event Date)
Closing Date: September 25, 2024
Context: The Company entered into a Note Purchase Agreement with a lender to secure financing and underwent a significant restructuring of its Board of Directors as a condition of the closing.
Key Financial Metrics and Obligations
- Loan Principal: $1,000,000
- Net Proceeds Received: $960,000
- Interest Rate: 18% per annum
- Maturity: 12 months from issuance
- Placement Agent Fee: $40,000 (paid to Westpark Capital, Inc.)
- Future Liquidity Option: Revolving line of credit up to $1,000,000 available upon filing a Registration Statement for a public offering with gross proceeds of at least $5,000,000.
Note: This filing does not provide revenue, profit, cash flow, or margin data for the reporting period.
Material Changes Versus Prior Period
Board of Directors Restructuring
Effective upon closing on September 25, 2024, the composition of the Board changed significantly:
- Resignations: Three directors resigned: Steven Gullans, Theresa Mock, and Elizabeth A. Graham (Chairperson). The resignations were not due to disagreements regarding operations or policies.
- Appointments: Three new directors designated by the Lender were appointed:
- Richard Paolone: Class I Director; appointed to Audit Committee and Compensation Committee (Chair).
- Avtar Dhaliwal: Class II Director; appointed to Compensation Committee and Nominating Committee (Chair).
- Katharyn (Katie) Field: Class III Director; appointed as Chairperson of the Board and member of Audit and Nominating Committees.
Guidance, Outlook, and Risks
- Conditions Precedent: Access to the additional $1,000,000 revolving line of credit is contingent on the Company filing a Registration Statement for an underwritten or best-efforts public offering with gross proceeds of at least $5,000,000.
- Covenants: The Note contains customary negative covenants and provisions relating to an Event of Default.
- Management Commentary: The filing states that the new directors are well-qualified due to their experience in corporate finance, strategy consulting, and executive leadership across various sectors including cannabis, technology, and mining.
Investor Verification Checklist
- Verify the Company's ability to raise the required $5,000,000 in gross proceeds to unlock the additional $1,000,000 revolving credit facility.
- Review the full text of the Note Purchase Agreement (Exhibit 10.1) and the Senior Note (Exhibit 4.1) for specific negative covenants and default triggers.
- Assess the impact of the 18% interest rate on future cash flow and profitability.
- Confirm the strategic alignment and independence of the new Board members appointed by the Lender.
- Monitor subsequent filings for the Registration Statement mentioned as a condition for the revolving credit line.